Atlas Trials

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Clinical trial NCT00654147 · COMPLETED

Trial details

NCT number
NCT00654147
Sponsor
Margaret A. Fischl, M.D.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2008-04-01
Primary completion
2012-01-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.